baber/WOPTO huggingface dataset:
Patent NZ-235962-A (NZ)
Title: Adsorption heat pump: adsorption/desorption reactors contain set of different compounds
Inventor: ROCKENFELLER UWE
IPC: F25B17/08
Filed: 1990-11-05
Abstract: A method of transferring and recovering energy comprises selecting a plurality of two or more different compounds comprising a solid reactant adsorbent and a gaseous reactant adsorbed thereon, each of said compounds having a different gaseous reactant vapor pressure, substantially independent of the concentration of the gaseous reactant, locating a first set of the different compounds in a first reactor and a second set of the different compounds in a second reactor, pressurizing the first reactor at a first pressure and the second reactor at a second pressure, supplying a heat transfer fluid at a first temperature along the first reactor in thermal communication with the first set of compounds, whereby said compounds desorb said gaseous reactant in endothermic reactions, supplying a heat transfer fluid at a second temperature, typically lower than the first temperature, along second reactor in thermal communication with the second set of compounds, whereby the compounds adsorb the gaseous reactant in exothermic reactions, and directing at least a portion of the heat released during the exothermic reactions or a least a portion of heat absorbed during the endothermic reactions to heat exchange means for energy recovery. The invention includes apparatus for carrying out the method.
Patent NZ-242551-A (NZ)
Title: 1-aryl-5(substituted alkylidene imino)pyrazoles; pharmaceutical and pesticidal compositions thereof; methods for preparation and control of arthropodic, nematodic, helminthic, and protozoan pests
Inventor: HUANG JAMIN
IPC: C07D401/12
Filed: 1992-04-29
Abstract: Pyrazoles of formula (I) are new. In (I), R1 = CN, NO2, halo, formyl, alkycarbonyl or cycloalkylcarbonyl; R2 = halo, alkyl, haloalkyl, alkoxy, haloalkoxy, NO2, thiocyanate, (or optd. mono- or di-alkyl substd.) sulphamoyl, or aminocarbonyl, alkoxycarbonyl or opt. substd. R9S(O)n; n = 0 to 2; R9 = alkyl, haloalkyl, cycloalkyl, halocycloalkyl, cyclo-alkyl- alkyl or halocycloalkyl alkyl; R3 = H, alkyl, alkoxy, alkylthio or di alkylamino; R4 = phenyl or 5-6 membered O,S and/or N, heteroaryl both opt. substd with -OH or a salt, -SH or a salt, halo, CN, NO2, alkyl, haloalkyl, alkoxy, -O- alkyl-O-, -O-halo alkyl-O-, haloalkoxy, alkanoyloxy, phenolic, tri-alkylsiloxy, phenyl, alkyl-S(O)n, halo alkyl-S(O)n, NR10R11, COR12, SO2R13; R10,R11 = H, alkyl, alkanoyl or haloalkanoyl; R12 = NR10R11 alkoxy, alkylthio, OH or a salt, H, alkyl or halo alkyl; R13 = NR10R11, alkoxy, alkylthio or OH or a salt; R5 = halo or alkyl; R6, R8 = H or F; R7 = H, alkyl, haloalkyl, alkoxy, haloalkoxy, CN, NO2, alkylcarbonyl, haloalkylcarbonyl, alkyl-S(O)n or halo alkyl-S(O)n; X = N or CR14; R14 = H, halo, CN, NO2, alkyl, alkylthio or alkoxy; where alkyl = 1-4C alkyl and cycloalkyl = 3-7C cycloalkyl. 17 Cpds. (I) are claimed e.g. 1-(2,6-dichloro-4-trifluoro methyl phenyl)-3-cyano-4- trifluoromethylsulphenyl-5- (4-hydroxy-3-methoxyphenyl) methylideneimino)pyrazole (Ia).
Patent NZ-243434-A (NZ)
Title: Oven for treating food products with a process vapour; food portions sprayed with the process vapour as they travel on a spiral conveyor
Inventor: CARIDIS ANDREW ANTHONY
IPC: A23L5/10
Filed: 1992-07-03
Abstract: A compact oven with a box-like housing (11) for efficient use of plant floor space encases a spiral food product carrying conveyor (12). A process vapor (50,56) is uniformly circulated within the housing by "plug fans" (49) with the inlet drawing vapor (50) from the central axial zone (31) of the spiral conveyor (12) and exhausting into plenums (53), which are arranged along the periphery of the conveyor and comprise indirect heat sources (13). The plenums have nozzles (54) orientated to project the process vapor laterally (56) towards the conveyor. <IMAGE>   <IMAGE>
Patent NZ-250103-A (NZ)
Title: Use of 1-imidazolyl derivatives in pharmaceutical compositions
Inventor: EECKHOUT CHRISTIAN
IPC: C07D233/96
Filed: 1993-10-29
Abstract: Use of imidazol-1-yl compounds of the general formula I     <IMAGE>  I  wherein R1 denotes lower alkyl or hydrogen; m represents 2 or 3, and n represents 2 or 3; or a physiologically acceptable acid addition salt thereof for treating functional disturbances of the lower intestinal tract in larger mammals and humans associated with increased pain sensitivity and/or anomalies in stool passage in the colon region.
Patent NZ-252828-A (NZ)
Title: Code division multiple access system
Inventor: DENT PAUL W
IPC: H04B7/26
Filed: 1993-04-13
Abstract: A Code Division Multiple Access (CDMA) communication system which contains a calling channel which is used to inform silent mobiles that they are being called. In the system, the calling channel is chosen to be the strongest overlapping signal so that it reaches mobiles which are located on the cells extreme boundaries. The interference other signals experience because they overlap with the calling channel may be avoided by having the mobiles first demodulate the calling channel signal and then subtract it out before demodulating their own signal.
Patent NZ-279988-A (NZ)
Title: Chain drive for construction toy system with plastic u-shaped links having recesses in arms to snap fit with adjacent links
Inventor: GLICKMAN JOEL I
IPC: F16H7/06
Filed: 1995-01-11
Abstract: A chain drive mechanism, especially for a construction toy system, is assembled with individual U-shaped chain link elements. The chain link elements are notched at their open ends and provided with bearing portions at their closed ends. The notched open ends are arranged for snap-fit attachment over the bearing portions of adjacent links, enabling a flexible chain of any length to be easily assembled. Drive pins, preferably coaxial with the bearing portions, project outwardly from each side of the chain links and are engagable with grooves of spaced-apart drive wheels, collectively forming a sprocket assembly. The drive wheels can be individual gear elements otherwise used in a toy construction system for gear drive mechanisms. The base portions of the U-shaped link elements are grooved transversely for the snap-fit attachment of construction toy connector parts, allowing the chain elements to carry other components.
Patent NZ-293600-A (NZ)
Title: Segmented rna virus with genetic modifications
Inventor: HOBOM GERD
IPC: C12N7/00
Filed: 1995-09-18
Abstract: RNA polymerase I transcription in vivo in transiently DNA-transfected cells has been used for expression of influenza vRNA molecules coding for chloramphenicol acetytransferase (CAT) in anti-sense orientation. Influenza virus superinfection served to provide viral RNA polymerase and other proteins for transcriptional conversion of minus-strand vRNA into plus-strand viral mRNA molecules expressing CAT activity. This system has been used for an analysis via nucleotide exchanges as well as deletions and insertions of both terminal segments of the vRNA sequence which cooperatively constitute the vRNA promoter structure. Several mutants with greatly enhanced expression rates over wild-type levels have been constructed, which also can be packaged and serially passaged into progeny virus. The data obtained for the mutations in various promoter elements support a model of consecutive, doublestrand vRNA promoter structures in binding of viral polymerase and initiation of RNA synthesis. Preparations of attenuated influenza virus for vaccination purposes include a single recombinant segment with promoter up mutation(s) for over-expression of an own or foreign gene product, which at the same time because of its over-replication serves to decrease the number of helper virus RNP segments. The same viruses further have been passaged through a step of ribozyme cleavage acting at one of the helper viral segments, which will delete this vital function and structure with high rates from the virus progeny. The resulting attenuated viruses will interact with their target cells in only one round of abortive infection, and are unable to produce viral progeny.
Patent NZ-320821-A (NZ)
Title: Protease modified cellulase compositions
Inventor: CLARKSON KATHLEEN A
IPC: A23K1/165
Filed: 1996-09-18
Abstract: The present invention relates to a method of modifying a cellulase composition comprising a proteolytically stable cellulase and a non-proteolytically cellulase comprising the steps: a)	adding protease to cellulase composition b)	incubating said cellulase/protease composition in aqueous solution under conditions sufficient to degrade the cellulase to produce a modified cellulase composition, wherein said proteolytically stable cellulase retains, in said modified cellulase composition at least 10% of the activity attributed to the stable cellulase composition. Also claimed is a detergent comprising the above modified cellulase composition, and the use of the composition in the treatment of lignocellulosic material, as an animal feed additive, and treating textiles.
Patent NZ-332010-A (NZ)
Title: Method for obtaining a pure (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile enantiomers of a pyridazinone derivative
Inventor: TIMMERBACKA MIKA
IPC: C07B53/00
Filed: 1997-03-27
Abstract: Described is a method for preparing optically substantially pure (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]propanedinitrile from racemic 6-(4-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone intermediate.  The end product is useful as a cardiotonic agent.  A novel crystalline polymorphic form of the end product is also described.
Patent NZ-337795-A (NZ)
Title: Death domain containing receptor 5 and it's use in the treatment of DR5 related disease
Inventor: NI JIAN
IPC: A61P25/28
Filed: 1998-03-17
Abstract: An isolated polynucleotide encoding human Death Domain Containing  Receptor 5 (DR5) comprising a first nucleic acid that is at least 90% identical to a second nucleic acid selected from SEQ ID NO:2.  The amino acid sequences for the complete polypeptide and the mature polypeptide encoded by the cDNA clone are contained in ATCC Deposit No. 97920.  Also described is a vector, a host cell and a pharmaceutical composition comprising the polypeptide.  Disclosed is the use of polypeptide in the preparation of a medicament for the treatment of cancer, inflammation; autoimmune disease, viral infection, and graft vs. host disease.  The translated polypeptide is a member of the TNF family of receptors.  It binds TNF-related apoptosis-inducing ligand (TRAIL).  Methods for producing a vector containing the polynucleotide, translating the polypeptide using a host cell, using the host cell to screen for ligand binding to polypeptide, identifying agonists and antagonists of the polypeptide, the production of antibody using the polypeptide, and the diagnosis of disease or susceptibility to disease related to underexpression of the polypeptide are disclosed.
Patent NZ-515613-A (NZ)
Title: Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
Inventor: NICHOLS DAVID E
IPC: A61P25/14
Filed: 2000-06-20
Abstract: Novel dopamine receptor ligands of formula (I) pharmaceutical formulations of such compounds, and a method using such compounds for treating a patient suffering from dopamine-related dysfunction of the central or peripheral nervous system, are described. The compounds are expected to be useful in treating Parkinson's disease, improving cognition, improving memory, improving the negative symptoms of schizophrenia, improving attention-deficit hyperactivity disorder and related developmental disorders, treating substance abuse disorders, and in treating various peripheral conditions where changes in dopamine receptor occupation affects physiological function, including organ perfusion, cardiovascular function, and selected endocrine and immune system functions.
Patent NZ-515822-A (NZ)
Title: The use of estrogen agonists/antagonists and testosterone for treating andropause
Inventor: MACLEAN DAVID BURTON
IPC: A61K31/44
Filed: 2001-11-29
Abstract: An estrogen agonist/antagonist and testosterone composition; useful for treating andropause in a male patient, or for treating gynecomastia, lipid disorders, cardiovascular disease, atherosclerosis, hypogonadism, benign prostatic hyperplasia, or osteopororsis, or for increasing libido, or maintaining or improving vascular reactivity in a male patient.
Patent NZ-523200-A (NZ)
Title: Methods of creating a tamper resistant informational article such as credit card with a hologram
Inventor: CURIEL YORAM
IPC: G11B7/24012
Filed: 2000-06-19
Abstract: A tamper resistant informational article (2) comprises a metal foil core (12), a hologram (60) formed in the metal foil core, information on the metal foil at least partially overlying the hologram, a resinous plastic material (100) encapsulating the hologram, the information and the metal foil, and the resinous plastic material being transparent in portions overlying the information. A tamper resistant informational article (350) comprises a transparent lens (534) having an upper surface and a lower surface, a hologram (360) formed in the lower surface thereof and information (364) applied to the hologram, a base (370) having a metal core (372) encapsulated in a resinous plastic material (374), and the upper surface of the base being secured to the lower surface of the lens, whereby the hologram and information will be protectively encased within the article. The tamper resistant informational article (350) can include a plurality of particles of a different material such as glass beads disposed within the resinous plastic material. The tamper resistant informational article (350) can include a magnetic media storage element secured to the base, and the magnetic media storage element is an elongated magnetic strip. The metal foil can be aluminum or copper foil. The information article can be a credit card, debit card, smart card, identification card, organization membership card and security card.
Patent NZ-524768-A (NZ)
Title: Publishing online operations and maintenance manuals for a building project
Inventor: SMITH STUART JAMES ROY
IPC: G06F19/00
Filed: 2003-03-17
Abstract: An online method for producing an operations and maintenance manual for a building or construction project, wherein the manual comprises content portions provided by a plurality of contractors, comprises: providing to the plurality of contractors access to an online data repository; obtaining respective content portions via a communications network, from the plurality of contractors; obtaining final approval of the content from an authorized representative of an owner of the building or construction project and publishing the manual upon obtaining final approval.
Patent NZ-525384-A (NZ)
Title: Apparatus and method for monitoring characteristics of pharmaceutical compositions during preparation in a fluidized bed
Inventor: FOLESTAD STAFFAN
IPC: G01N21/35
Filed: 2001-10-16
Abstract: Disclosed is a method and apparatus for monitoring characteristics of a pharmaceutical composition during preparation thereof by in the process vessel (1) of a fluidized bed apparatus, wherein a measuring device (11, 11') performs a spectometric measurement on the pharmaceutical composition in a wetting zone (B) into which a processing fluid is injected.
Patent NZ-525742-A (NZ)
Title: NMDA receptor agonist pharmaceutical compositions
Inventor: HONG JINYANG
IPC: A61P25/28
Filed: 2001-12-05
Abstract: Discloses the use of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol in the preparation of a pharmaceutical composition comprising a pharmaceutically effective amount of (1S,2S)-1-(4-hydroxyphenyl)-2-(4- hydroxy-4-phenylpiperidin-1-yl)-1-propanol or a pharmaceutically acceptable salt thereof and water, wherein said composition contains less than about 2 parts per million of free copper ion and less than about 2 parts per million of free iron ion. Further disclosed is a use of the disclosed pharmaceutical composition in the preparation of a medicament for the treatment of stroke, spinal cord trauma, traumatic brain injury, multiinfarct dementia, CNS degenerative diseases, epilepsy, amyotrophic lateral sclerosis, pain, AIDS dementia, psychotic conditions, drug addictions, migraine, hypoglycemia, anxiolytic conditions, urinary incontinence or an ischemic event arising from CNS surgery, open heart surgery or any procedure during which the function of the cardiovascular system is compromised.
Patent NZ-527973-A (NZ)
Title: Eyewear with interchangable temples
Inventor: POLOVIN TERRENCE PETER
IPC: G02C5/00
Filed: 2003-09-02
Abstract: A pair of glasses that includes a lens frame (11) supporting a pair of lenses (12). The frame (11) includes rearwardly extending temple mountings (13) to which there is releasably attached temples (14). The temples (14) are releasably attached to the mountings (13) by means of clip assemblies (15).
Patent NZ-530018-A (NZ)
Title: Method of cloning porcine animals
Inventor: DAMIANI PHILIP
IPC: C12N5/073
Filed: 1999-11-12
Abstract: Methods for preparing porcine embryo capable of developing into a live born porcine animal comprise obtaining a totipotent porcine nuclear donor cell from a cell culture and forming a cybrid by translocating the cell or nucleus thereof into an enucleated porcine oocyte which prior to enucleation has been matured for between 42 and 56 hours, and which before, during or after translocation the oocytes is activated. The cybrid is then cultured to form a porcine embryo, which can then be transferred into a recipient porcine female to generate a live born porcine animal. Preferably the activation step comprises incubating the cells in a medium comprising ionomycin and/or 6-dimethylaminopurine. (62) Divided out of 512357
Patent NZ-546926-A (NZ)
Title: Headband device for an oxygen mask, and method for the production thereof
Inventor: LANG BERND
IPC: A62B18/08
Filed: 2004-11-11
Abstract: The disclosure relates to a headband device used for applying an oxygen mask in a user's facial area. Said headband device comprises a flexible band member that is provided with upper and lower band sections and is used for transmitting the mask-retaining forces required for applying the oxygen mask. At least some sections of the band member are made of a foamed plastic material. The invention further relates to an application apparatus (102) for an oxygen mask, comprising a headband device which extends around the back of a user's head. The headband device encompasses a support structure (S) made of a material that can at least once be temporarily brought into a state in which at least some sections of the headband device can be individually adjusted to the shape of the back of the user's head.
Patent NZ-548688-A (NZ)
Title: Suppressing fluid communication to or from a wellbore
Inventor: BOSSAERTS JAN DIRK
IPC: C09K8/512
Filed: 2005-02-10
Abstract: To suppress leakage of drilling fluid into a subsurface formation surrounding a wellbore a fluid 28 carrying solid particles 29, the solid particles containing at least 50 wt% of a reactive curable polymer or polymer composition, is introduced into the bore so that the carrier fluid passes through an interface 20 between the bore and its surroundings whilst the particles 29 accumulate at the interface where they form a solid plug that suppresses fluid communication through the interface.
Patent NZ-551249-A (NZ)
Title: Synergism of galactooligosaccharidies (GOS) and polyfructose for use in treating allergy, eczema and atopic dermatitis
Inventor: SPEELMANS GELSKE
IPC: A23L33/00
Filed: 2005-05-17
Abstract: The use of compositions comprising galacto-oligosaccharides and polyfructose for the treatment or prevention of allergy, eczema or atopic diseases. The polyfructose is inulin and has an average degree of polymerisation in the range of 20-150. The daily dose of galacto-oligosaccharides and polyfructose ranges from 1-30 g/day. In a first composition the composition is administered in the range of 100-1500 ml.In a second composition the composition does not comprise Bifidobacterium breve and the composition does not comprise an acid oligosaccharide comprising at least one terminal uronic acid unit.
Patent NZ-553731-A (NZ)
Title: Topically applicable pharmaceutical preparation of roflumilast and liquid paraffin
Inventor: BOLLE CHRISTINA
IPC: A61K9/70
Filed: 2003-05-27
Abstract: Disclosed is a topically applicable pharmaceutical preparation comprising an active pharmaceutical ingredient together with one or more pharmaceutical carriers and/or excipients suitable for topical administration, where the active pharmaceutical ingredient is a compound selected from the group consisting of roflumilast, salt of roflumilast or a N-oxide of the pyridine residue of roflumilast or salt thereof, which topically applicable pharmaceutical preparation is an ointment and which contains a paraffin which is suitable for topical use and is liquid at body temperature. Also disclosed is the use of these topically applicable pharmaceutical preparations (which may be in the form of transdermal therapeutical system (TTS)) for the production of a medicament for the systemic treatment of a disease selected from the group consisting of acute or chronic airway disorders of various aetiologies, disorders of the arthritic type or for the treatment of various dermatoses of the skin.
Patent NZ-565120-A (NZ)
Title: Cheese with sodium gluconate to inhibit calcium lactate crystal formation
Inventor: METZGER LLOYD E
IPC: A23C19/064
Filed: 2006-08-03
Abstract: Disclosed is a method of making cheese comprising: a)providing sodium gluconate; b) developing acidity in milk and setting the milk; C) separating whey from the set milk to produce curd; d) adding salt to the curd; and e) pressing the salted curd into cheese; wherein the sodium gluconate is added to one or more of the milk, the set milk, or the curd. Also disclosed is an aged cheese comprising calcium, lactate and gluconate.
Patent NZ-575337-A (NZ)
Title: 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
Inventor: ALMARIO GARCIA ANTONIO
IPC: C07D471/04
Filed: 2007-09-19
Abstract: Disclosed is a compound corresponding to formula (I) e.g. { 4-[2-(4-pyrrolidin-1-ylphenypimidazo[1,2-c]pyridin-6-yl]phenyl] methanol in which R1 is: a phenyl group or a naphthyl group, R2, R3 and R4 are defined in the specification in the form of a base or of an addition salt with an acid for use in the treatment or prevention of Parkinson's Disease, Alzheimer's Disease, tauopathies and multiple sclerosis, depression, substance dependency and attention deficit hyperactivity disorders. Also disclosed is a process for obtaining the compounds of formula (I) wherein they are obtained by means of a coupling reaction, catalysed by a metal, between a 2-arylimidazopyridine, and an aryl stannane or boronate derivative,
Patent NZ-576994-A (NZ)
Title: Package containing multiple transaction cards and having a package identifier for activating the cards
Inventor: SINGH LALIT
IPC: G06K5/00
Filed: 2007-11-09
Abstract: Disclosed is a package assembly enabling the processing of a plurality of transaction cards (203) at a point of sale. The assembly comprises at least two transaction cards (203) and a package (200) for securing the cards (203). Each of the cards (203) has a unique transaction card identifier (111) and each transaction card identifier (111) corresponds to a unique account. A unique identifier (250) is also associated with the package (200) and is separate from the transaction cards (203). The unique package identifier (250) provides for activation of the plurality of transaction cards (203).